
Lansdowne Partners
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Lansdowne Partners is an alternative investment management firm that focused on equity portfolios.
Investor Profile
Lansdowne Partners has made 39 investments, with 2 in the past 12 months and 23% as lead.
Stage Focus
- Series Unknown (26%)
- Series A (21%)
- Series B (21%)
- Series C (15%)
- Seed (5%)
- Private Equity (5%)
- Series G (3%)
- Undisclosed (3%)
- Post Ipo Debt (3%)
Country Focus
- United Kingdom (69%)
- Austria (8%)
- United States (5%)
- Ireland (5%)
- Switzerland (5%)
- Sweden (3%)
- France (3%)
- Germany (3%)
Industry Focus
- Biotechnology
- Genetics
- Biopharma
- Health Care
- Information Technology
- Life Science
- Therapeutics
- Medical
- Financial Services
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.